BRITTANY JOHNSON: Open Payments
NPI 1457952400 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 49 payments from 9 companies in 2025. Trend: 2023 $59 · 2024 $538 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $450 |
| Supernus Pharmaceuticals, Inc. | 27 | $351 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Braeburn Inc. | 1 | $116 |
| Janssen Pharmaceuticals, Inc | 1 | $107 |
| Collegium Pharmaceutical, Inc. | 1 | $105 |
| ABBVIE INC. | 4 | $90 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
Products named: CAPLYTA, Qelbree, Auvelity, COBENFY, BRIXADI, SPRAVATO, Jornay PM, VRAYLAR.
Industry payments across LA — which companies pay providers there.
